Author:
Nag Kakon,Haq Sarker Md. Enamul,Kumar Samir,Chakraborty Sourav,Khan Habiba,Islam Md. Jikrul,Rahman Khan Md. Maksusdur,Rahman Chowdhury Md. Mashfiqur,Roy Rony,Roy Ratan,Biswas Bipul Kumar,Hasan Bappi Md. Emrul,Mohiuddin Mohammad,Sultana Naznin
Abstract
AbstractWell-characterized and scalable downstream process for purification of biologics is extremely demanding for delivering quality therapeutics to patients at a reasonable price. Erythropoietin (EPO) is a blockbuster biologic with diverse clinical applications but its application is limited to financially well-off societies due to high price. The high price of EPO is associated with the technical difficulties related to the purification challenge to obtain qualified product with a cost-effective defined process. Though there are reports for purification of EPO but there is no report of well-characterized downstream process with critical process parameters (CPPs) that can deliver EPO consistently satisfying the quality target product profile (QTPP), which is a critical regulatory requirement. To advance the field, we applied quality by design (QbD) principle and design of experiment (DoE) protocol to establish an effective process, which is scalable up to 100× batch size satisfying QTPP. We have successfully transformed the process from static mode to dynamic mode and validated. Insignificant variation (p> 0.05) within and between 1×, 10× and 100× batches showed that the process is reproducible and seamlessly scalable. The biochemical analysis along with the biofunctionality data ensures that the products from different-scale batches were indifferent and comparable to a reference product. Our study thereby established a robust and scalable downstream process of EPO biosimilar satisfying QTPP. The technological scheme presented here can speed-up the production of not only EPO but many other life-saving biologics and make them available to mass population at a reduced cost.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. A Review on Erythropietin in Pregnancy
2. Erythropoietin
3. Recombinant Human Erythropoietin. The problem of glycosylation
4. Structural characterization of human erythropoietin.
5. SCHMIDT Physico-Chemical Characterization and Biological Evaluation of Recombinant Human Erythropoietin in Pharmaceutical Products;Latin American Journal of Pharmacy,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献